Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women - PREFER a Randomized, Placebo-Controlled Study
Fiche du document
2014
- doi: 10.1371/journal.pone.0094217
- issn: 1932-6203
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1371/journal.pone.0094217
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24751822
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1932-6203
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_4677D373E29F0
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Mots-clés
Forensic Medicine; Traffic; ToxicologySujets proches
Womyn Wimmin Woman Womon Human females Exhaustion Tiredness Lassitude Weariness Women's workCiter ce document
B. Favrat et al., « Evaluation of a Single Dose of Ferric Carboxymaltose in Fatigued, Iron-Deficient Women - PREFER a Randomized, Placebo-Controlled Study », Serveur académique Lausannois, ID : 10.1371/journal.pone.0094217
Métriques
Partage / Export
Résumé
BACKGROUND: Unexplained fatigue is often left untreated or treated with antidepressants. This randomized, placebo-controlled, single-blinded study evaluated the efficacy and tolerability of single-dose intravenous ferric carboxymaltose (FCM) in iron-deficient, premenopausal women with symptomatic, unexplained fatigue. METHODS: Fatigued women (Piper Fatigue Scale [PFS] score ≥5) with iron deficiency (ferritin